| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6183608 | Gynecologic Oncology | 2014 | 9 Pages |
Abstract
Silencing of AKR1C3 increases LCN2 expression and inhibits metastasis in cervical cancer. Both AKR1C3 and LCN2 serve as molecular targets for cancer therapy to improve the clinical outcome of cervical cancer patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Chih-Hsien Wu, Jiunn-Liang Ko, Shiuan-Chih Chen, Yu-Wen Lin, Chih-Ping Han, Ti-Yuan Yang, Ming-Hsien Chien, Po-Hui Wang,